Ticker Symbol: BRLIR
Brilliant Acquisition Corp - Tradeable Rights - July 2020
$0.34 - 09-10-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Right
CIK:0001787518
Company Profile
genedx was founded in 2000 by two scientists from the national institutes of health (nih) to address the needs of patients and clinicians in diagnosing rare inherited disorders. currently, genedx offers testing for more than 400 rare mendelian disorders, and gene panels for inherited cardiac disorders, inherited cancer syndromes, neurological disorders, and mitochondrial disorders. in addition, genedx also offers whole exome sequencing and whole genome chromosomal microarray testing. our highly trained and experienced physicians, geneticists, and genetic counselors work as a team to bring gene discoveries to clinical medicine for use in direct patient care. for more information, please visit our website at www.genedx.com
Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: N/A
Website: N/A
CEO: N/A
Tags:
- Finance
- Financial Conglomerates
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.17
Change:
$0.00
(
-2.63%)
Days Range: $0.16 - $0.17
Beta: -
52wk. High: $0.30
52wk. Low: $0.02
Ytd. Change -10.74%
50 Day Moving Average: $0.19
200 Day Moving Average: $0.18
Shares Outstanding: 1814696
Valuation
Market Cap: 2.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A